The role of Fc-FcγR interactions in IgG-mediated microbial neutralization

被引:128
作者
Bournazos, Stylianos [1 ]
DiLillo, David J. [1 ]
Ravetch, Jeffrey V. [1 ]
机构
[1] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA
关键词
RECEPTOR ENGAGEMENT DRIVES; IN-VIVO; MONOCLONAL-ANTIBODY; HUMANIZED MICE; CAPSULAR POLYSACCHARIDE; CRYPTOCOCCUS-NEOFORMANS; UNIVERSAL VACCINE; EFFECTOR FUNCTION; LIPID RAFTS; MOUSE MODEL;
D O I
10.1084/jem.20151267
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antibodies are bifunctional molecules, containing a variable Fab domain that mediates binding specificity and a constant Fc domain that bridges antibody-coated targets with Fc gamma R-expressing cells that mediate effector functions. Although traditional mechanisms of antibody-mediated neutralization of microbes have been largely thought to result from Fab-antigen interactions, recent studies suggest that recruitment of Fc gamma R-expressing effector cells by antibodies is a major in vivo mechanism of antibody-mediated protection from infection. In this article, we review Fc gamma R biology, compare mammalian Fc gamma R families, and summarize recent evidence demonstrating the crucial role that Fc-Fc gamma R interactions play during in vivo protection from infection.
引用
收藏
页码:1361 / 1369
页数:9
相关论文
共 72 条
[41]   Treatment with Monoclonal Antibodies against Clostridium difficile Toxins [J].
Lowy, Israel ;
Molrine, Deborah C. ;
Leav, Brett A. ;
Blair, Barbra M. ;
Baxter, Roger ;
Gerding, Dale N. ;
Nichol, Geoffrey ;
Thomas, William D., Jr. ;
Leney, Mark ;
Sloan, Susan ;
Hay, Catherine A. ;
Ambrosino, Donna M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (03) :197-205
[42]   Impact of Immune Complex Size and Glycosylation on IgG Binding to Human FcγRs [J].
Lux, Anja ;
Yu, Xiaojie ;
Scanlan, Chris N. ;
Nimmerjahn, Falk .
JOURNAL OF IMMUNOLOGY, 2013, 190 (08) :4315-4323
[43]   Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies [J].
Mascola, JR ;
Stiegler, G ;
VanCott, TC ;
Katinger, H ;
Carpenter, CB ;
Hanson, CE ;
Beary, H ;
Hayes, D ;
Frankel, SS ;
Birx, DL ;
Lewis, MG .
NATURE MEDICINE, 2000, 6 (02) :207-210
[44]   Raxibacumab for the Treatment of Inhalational Anthrax. [J].
Migone, Thi-Sau ;
Subramanian, G. Mani ;
Zhong, John ;
Healey, Letha M. ;
Corey, Al ;
Devalaraja, Matt ;
Lo, Larry ;
Ullrich, Stephen ;
Zimmerman, Janelle ;
Chen, Andrew ;
Lewis, Maggie ;
Meister, Gabriel ;
Gillum, Karen ;
Sanford, Daniel ;
Mott, Jason ;
Bolmer, Sally D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (02) :135-144
[45]   Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape [J].
Moore, Penny L. ;
Gray, Elin S. ;
Wibmer, C. Kurt ;
Bhiman, Jinal N. ;
Nonyane, Molati ;
Sheward, Daniel J. ;
Hermanus, Tandile ;
Bajimaya, Shringkhala ;
Tumba, Nancy L. ;
Abrahams, Melissa-Rose ;
Lambson, Bronwen E. ;
Ranchobe, Nthabeleng ;
Ping, Lihua ;
Ngandu, Nobubelo ;
Karim, Quarraisha Abdool ;
Karim, Salim S. Abdool ;
Swanstrom, Ronald I. ;
Seaman, Michael S. ;
Williamson, Carolyn ;
Morris, Lynn .
NATURE MEDICINE, 2012, 18 (11) :1688-+
[46]   Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer [J].
Musolino, Antonino ;
Naldi, Nadia ;
Bortesi, Beatrice ;
Pezzuolo, Debora ;
Capelletti, Marzia ;
Missale, Gabriele ;
Laccabue, Diletta ;
Zerbini, Alessandro ;
Camisa, Roberta ;
Bisagni, Giancarlo ;
Neri, Tauro Maria ;
Ardizzoni, Andrea .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (11) :1789-1796
[47]  
Natsume A, 2008, DRUG DES DEV THER, V3, P7
[48]   Fcγ receptors:: Old friends and new family members [J].
Nimmerjahn, F ;
Ravetch, JV .
IMMUNITY, 2006, 24 (01) :19-28
[49]   Divergent immunoglobulin G subclass activity through selective Fc receptor binding [J].
Nimmerjahn, F ;
Ravetch, JV .
SCIENCE, 2005, 310 (5753) :1510-1512
[50]   Fcγ receptors as regulators of immune responses [J].
Nimmerjahn, Falk ;
Ravetch, Jeffrey V. .
NATURE REVIEWS IMMUNOLOGY, 2008, 8 (01) :34-47